shortagewatch

Home / Cancer and immune system / Risankizumab

ATC L04AC18 · Interleukin Inhibitors · updated 2 Nov 2026

Risankizumab shortage

As of 2 Nov 2026, Risankizumab has a reported shortage in 1 of the 16 countries we track (Czechia), covering 1 product from 1 company.

Is there a Risankizumab shortage?

Yes. As of 2 Nov 2026, Risankizumab is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 31 Jan 2028 (Czechia).

Countries1/16
Products1packs or presentations
Companies11 listed
Short since31 Jan 20242.8 years ago
Earliest return31 Jan 2028company estimate
Main reasonCommercial decision or withdrawal
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia1 product shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Czechia
202520262028SKYRIZI 150MG 150MG INJ SOL PEP 1X1MLSKYRIZI 150MG 150MG INJ SOL PEP 1X1MLtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
AbbVie1 ABBV

Listed: AbbVie ABBV · NYSE

Compared with similar medicines

ATC group L04AC · Interleukin Inhibitors
Tocilizumab5/16Ustekinumab4/16Basiliximab2/16Secukinumab2/16Spesolimab2/16Daclizumab1/16Mirikizumab1/16Risankizumab1/16

Affected products

CountryProductCompanySinceExpected backReason
CZSKYRIZI 150MG 150MG INJ SOL PEP 1X1MLAbbVie Deutschland GmbH & Co.KG, Ludwigshafen31 Jan 202431 Jan 2028Commercial decision or withdrawal
Obchodní/marketingové důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.

Questions

Is there a Risankizumab shortage?

Yes. As of 2 Nov 2026, Risankizumab is reported short in 1 of the 16 countries we track: Czechia. The earliest expected return is 31 Jan 2028 (Czechia).

When will Risankizumab be back in stock?

Companies expect supply back from 31 Jan 2028 in Czechia; Czechia: 31 Jan 2028. These are company estimates reported to each authority.

Why is Risankizumab in short supply?

The most common reason reported is: commercial decision or withdrawal. Reasons by product are listed in the table below.

Which companies have Risankizumab shortages?

AbbVie.